Carrie DiMarzio has dedicated her career to creating a better future by using her leadership skills in tandem with her expertise in science and engineering. DiMarzio is the CEO of BioMedInnovations LLC (BMI) and Industrial Hard Carbon LLC (IHC).

At BMI, DiMarzio leads a team of experts in perfusion technology that will advance organ transplantation and novel ex vivo laboratory research - both projects have the potential to save thousands of lives. She guides partnerships of BMI with organizations such as the Wake Forest Institute for Regenerative Medicine (WFIRM), Lawrence Livermore National Laboratory (LLNL), Duke Ex-Vivo Organ Laboratory (DEVOL), Cystic Fibrosis Foundation, and RegenMed Development Organization (ReMDO). Additionally, DiMarzio also serves on the Executive Leadership Council Board of ReMDO. During her time at BMI, DiMarzio has led successful negotiations with the US FDA, gaining FDA EUA status for BMI's SuppleVent™ device for use during the COVID-19 pandemic. DiMarzio's current endeavor is guiding OrganBankTM technology - a proprietary organ preservation system - through the FDA clearance project.

As noted, DiMarzio also serves as CEO for IHC, a precision engineering business that serves the bio-medical, aerospace, and automotive sectors, providing microscopically thin and diamond-like hard surface film modifications that vastly improve equipment performance and durability.

DiMarzio has relevant business experience in sales and marketing as well as quality control, can help to guide business owners on the difficult road toward increased efficiency and productivity, and has an in-depth familiarity with human capital development. DiMarzio is known for her attention to detail, her equal commitment to her company, team, and stakeholders, and her remarkable ability to elicit 'personal bests' from each member of the high-performing teams under her charge.

When DiMarzio is not making a difference by managing cutting-edge projects at these two innovative companies based in North Carolina, she engages deeply with her local church and community, coaches female sports for the local schools, and is significantly involved in global outreach programs to provide for those in need.

25+ years of life science experience, including over 20 years with Johnson & Johnson, a leading pharmaceutical and medical device company.

Wide range of leadership positions in the commercialization and development of drugs and devices. Notable career experiences include planning launches for novel devices and drugs, establishing research, development and commercial partnerships, and overseeing payor strategy and patient support services for a multi-billion-dollar product franchise. Co-invented and led the development of a diagnostic device now under ongoing approval by regulators around the globe.

Bachelor of Science in Chemical Engineering from Rice University and MBA from Columbia Business School.

Distinguished Professor and Vice Chair Clinical Affairs and Chief of the Division of Abdominal Transplant at UNC.

2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.

In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.

One of America’s foremost expert perfusionists
14 years from research and development of perfusion tech
Co-author of many peer reviewed publications and papers
Leading the BMI lab at Duke Hospital

World leading expert in design and development of advanced and automated perfusion systems
30+ years of engineering experience from US security clearance systems
US veteran who has held security clearance

30+ years of advanced medical program development and engineering
Worked on multiple groundbreaking medical advancement systems

25+ years executive experience in strategic business development in multiple jurisdictions
Special Advisor on Capitol Hill
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
Mark helped forge BMI’s relationships with Dr. Prabir Roy-Chaudhury MD, Ph.D, FRCP, co-Director of the Kidney Center UNC Chapel Hill, and with Dr. Tony Atala, MD, founding Director of the Wake Forest Institute of Regenerative Medicine, and negotiated the establishment of a new Recove laboratory based at the WFIRM ReMDO RegeneratOR in Winston-Salem.

Duane Beaudot has twenty-three years of experience in marketing and design. Eighteen of those years were dedicated to regenerative medical science and cancer research as the Creative Director at AlphaMed Press (AMP), the publisher of the peer-reviewed journals STEM CELLS, STEM CELLS Translational Medicine, and The Oncologist and, since 2022, as the Marketing and Creative Director for Beaudot Creative.

At AMP, Beaudot oversaw all aspects of company branding and forward-facing entities, which included journal layouts, websites, logos, trade booths, advertisements, brochures, presentations, videos, animations, and webinars. Beaudot helped to launch a non-profit – The Society for Translational Oncology – and a peer-reviewed journal – STEM CELLS Translational Medicine – the first journal dedicated to bringing regenerative medicine from the “bench to bedside” led by Editor-in-Chief Dr. Anthony Atala. Both remain successful today, over a decade after their startup. As the Creative Director, Beaudot also worked in tandem with the Marketing Department and external sponsors to develop market concepts and advertising campaigns.

Over the years, Beaudot has had the opportunity to loan his talents to multiple concerns, including partnerships with institutions such as the Massachusetts General Hospital, the ASCO Conquer Cancer Foundation, Wake Forest Institute for Regenerative Medicine, the Regenerative Medicine Foundation, RegenMed Development Organization (ReMDO), UNC Lineberger Comprehensive Cancer Center, European Cancer Concord, CEO Roundtable on Cancer, and Project Data Sphere.

Duane’s passion for design, branding, and marketing is only surpassed by his commitment to bettering patients’ quality of life by aiding doctors and scientists in disseminating their findings to evolve research and development in medical and scientific fields to make a better future and, ultimately, save and improve lives.